,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2016-12-30 00:40:00,The consumer products industry is bracing for another year of sluggish global growth and brutal competition.,0.18259292840957642,0.48990967869758606,0.3274973928928375,negative,-0.30731675028800964
1,2016-12-30 00:40:00,"Those dynamics mean that Procter & Gamble (NYSE: PG) , despite its improved portfolio and lower cost structure, might again post disappointing operating results.",0.02234118990600109,0.9644070267677307,0.01325179822742939,negative,-0.9420658349990845
2,2016-12-30 00:40:00,"It is targeting 2% organic sales gains in 2017, which would mark an improvement over the prior year, but still implies a third straight year of market share declines.",0.29040682315826416,0.687991201877594,0.021601932123303413,negative,-0.39758437871932983
3,2016-12-30 00:40:00,"Investors looking for brighter prospects should consider two other blue-chip giants, 3M (NYSE: MMM) and Johnson & Johnson (NYSE: JNJ) .",0.4848639965057373,0.012986714020371437,0.5021492838859558,neutral,0.4718772768974304
4,2016-12-30 00:40:00,"Both are exposed to the consumer goods industry, but also get significant chunks of sales and profits from faster-growing segments.",0.293545126914978,0.009847933426499367,0.6966069936752319,neutral,0.2836971879005432
5,2016-12-30 00:40:00,Sales growth is for the past complete fiscal year and excludes currency impacts and brand sales.,0.013532971031963825,0.008183895610272884,0.978283166885376,neutral,0.005349075421690941
6,2016-12-30 00:40:00,Sources: Company financial filings and S&P Global Market Intelligence .,0.011225646361708641,0.00983241107314825,0.9789419174194336,neutral,0.0013932352885603905
7,2016-12-30 00:40:00,"Like P&G, 3M is seeing its growth improve at a stubbornly weak pace right now.",0.24862845242023468,0.697718620300293,0.053652871400117874,negative,-0.4490901827812195
8,2016-12-30 00:40:00,"Organic sales are projected to be flat in fiscal year 2016, compared to a 1% dip the prior year.",0.02147946134209633,0.9613965749740601,0.017123935744166374,negative,-0.9399170875549316
9,2016-12-30 00:40:00,"The growth should accelerate solidly from there, as management forecasts 2% gains for 2017.",0.9482774138450623,0.015334619209170341,0.036387983709573746,positive,0.932942807674408
10,2016-12-30 00:40:00,The conglomerate enjoys significantly stronger profitability than P&G.,0.9312734007835388,0.025278687477111816,0.04344795644283295,positive,0.905994713306427
11,2016-12-30 00:40:00,"In fact, operating margins across each of its five core business divisions were 22% or better last quarter.",0.8891527652740479,0.08250349014997482,0.028343623504042625,positive,0.8066492676734924
12,2016-12-30 00:40:00,"Its consumer products segment was a standout performer during the period, with sales up 4% and operating margin north of 26%.",0.9568392634391785,0.02219141647219658,0.02096935547888279,positive,0.9346478581428528
13,2016-12-30 00:40:00,"By contrast, P&G posted a 3% uptick and profitability of 21%.",0.9415059685707092,0.02697153389453888,0.031522590667009354,positive,0.9145344495773315
14,2016-12-30 00:40:00,"Not only does 3M's operating margin trounce P&G's 20% figure, but 3M's profitability has been consistently higher and more stable over the last six years.",0.9552758932113647,0.017907604575157166,0.026816481724381447,positive,0.9373682737350464
15,2016-12-30 00:40:00,"As a result, the company has more cash to invest in the business and to return to shareholders -- without needing to resort to the types of major brand divestments that P&G has.",0.8444579243659973,0.014173900708556175,0.14136813580989838,positive,0.8302839994430542
16,2016-12-30 00:40:00,"Johnson & Johnson has a large consumer products division that is enduring weak growth, roughly comparable to P&G's.",0.01859937235713005,0.9533717036247253,0.028028862550854683,negative,-0.9347723126411438
17,2016-12-30 00:40:00,"Global brands like Listerine, Aveeno, and Nicorette have helped keep sales moving in the right direction, but that rise amounts to just 1% over the last nine months.",0.9260199069976807,0.03444987162947655,0.03953012451529503,positive,0.8915700316429138
18,2016-12-30 00:40:00,"The sluggishness was more than offset by strong results in its two bigger divisions, though.",0.9146173596382141,0.03433796763420105,0.05104466900229454,positive,0.8802794218063354
19,2016-12-30 00:40:00,Medical device sales rose 3% last quarter and the company's pharmaceutical segment spiked higher by 11%.,0.9519929885864258,0.018346380442380905,0.029660677537322044,positive,0.9336466193199158
20,2016-12-30 00:40:00,"Bottom line, organic sales rose 6% in the third quarter, roughly double P&G's pace.",0.9568524956703186,0.019085614010691643,0.024061983451247215,positive,0.9377669095993042
21,2016-12-30 00:40:00,"While both companies admit that innovation is critical to the health of their business, Johnson & Johnson is faring much better on this score.",0.9008704423904419,0.030543416738510132,0.06858623027801514,positive,0.8703269958496094
22,2016-12-30 00:40:00,"Thanks to the $9 billion it dedicates annually to research and development, the healthcare giant consistently churns out new blockbuster brands.",0.8127098083496094,0.014823994599282742,0.17246617376804352,positive,0.7978858351707458
23,2016-12-30 00:40:00,Over 25% of sales last year came from products that were launched over just the past five years.,0.033974580466747284,0.00681287469342351,0.9592125415802002,neutral,0.02716170623898506
24,2016-12-30 00:40:00,"P&G, meanwhile, hasn't introduced a new billion-dollar franchise in over a decade.",0.18759997189044952,0.044127658009529114,0.7682723999023438,neutral,0.1434723138809204
25,2016-12-30 00:40:00,"P&G's slight valuation premium of 23 times earnings compared to 21 for Johnson & Johnson and 22 for 3M, reflects the growing optimism that the operations are about to take a sharp turn higher .",0.9282888174057007,0.03884829953312874,0.03286287188529968,positive,0.8894405364990234
26,2016-12-30 00:40:00,"After all, the company has whittled its brand portfolio down to just the fastest growing, most profitable products at the expense of only a small portion of revenue.",0.13268376886844635,0.27468210458755493,0.5926341414451599,neutral,-0.14199833571910858
27,2016-12-30 00:40:00,"At the same time, its cost burden is far lower than it was just three years ago.",0.2764180302619934,0.6143984198570251,0.10918359458446503,negative,-0.33798038959503174
28,2016-12-30 00:40:00,"Yet rather than bet on the potential for faster growth or better margins, investors might prefer buying businesses that already demonstrate these important characteristics, especially when they come at a discount to P&G's valuation.",0.40218237042427063,0.026964474469423294,0.5708532333374023,neutral,0.37521788477897644
29,2016-12-30 00:40:00,"10 stocks we like better than Procter and Gamble

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.",0.12097388505935669,0.02674618735909462,0.8522799611091614,neutral,0.09422770142555237
30,2016-12-30 00:40:00,"After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has tripled the market.",0.46925464272499084,0.07301506400108337,0.4577302634716034,positive,0.39623957872390747
31,2016-12-30 00:40:00,"*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Procter and Gamble wasn't one of them!",0.178693026304245,0.013100427575409412,0.8082065582275391,neutral,0.16559259593486786
32,2016-12-30 00:40:00,That's right -- they think these 10 stocks are even better buys.,0.8146857619285583,0.02307075634598732,0.16224350035190582,positive,0.7916150093078613
33,2016-12-30 00:40:00,Click here to learn about these picks!,0.0694708302617073,0.055800698697566986,0.8747285008430481,neutral,0.01367013156414032
34,2016-12-30 00:40:00,Demitrios Kalogeropoulos has no position in any stocks mentioned.,0.01237286813557148,0.0730053186416626,0.9146218299865723,neutral,-0.06063245236873627
35,2016-12-30 00:40:00,The Motley Fool recommends Johnson and Johnson.,0.0684378445148468,0.0328618586063385,0.8987002968788147,neutral,0.0355759859085083
36,2016-12-30 00:40:00,The Motley Fool has a disclosure policy .,0.016547100618481636,0.017303917557001114,0.9661489725112915,neutral,-0.0007568169385194778
37,2016-12-30 00:40:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
